Targeting the IL-23/IL-17 axis for the treatment of psoriasis and psoriatic arthritis
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting the IL-23/IL-17 axis for the treatment of psoriasis and psoriatic arthritis
Authors
Keywords
-
Journal
EXPERT OPINION ON BIOLOGICAL THERAPY
Volume 15, Issue 12, Pages 1727-1737
Publisher
Informa Healthcare
Online
2015-09-07
DOI
10.1517/14712598.2015.1084284
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tildrakizumab, a novel anti-IL-23 monoclonal antibody, is unaffected by ethnic variability in Caucasian, Chinese, and Japanese subjects
- (2015) Anthe Zandvliet et al. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
- Efficacy and safety of brodalumab in subpopulations of patients with difficult-to-treat moderate-to-severe plaque psoriasis
- (2015) Kim Papp et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Efficacy and safety of the anti-IL-12/23 p40 monoclonal antibody, ustekinumab, in patients with active psoriatic arthritis despite conventional non-biological and biological anti-tumour necrosis factor therapy: 6-month and 1-year results of the phase 3, multicentre, double-blind, placebo-controlled, randomised PSUMMIT 2 trial
- (2014) Christopher Ritchlin et al. ANNALS OF THE RHEUMATIC DISEASES
- Th17 and regulatory T cell balance in autoimmune and inflammatory diseases
- (2014) Mélissa Noack et al. AUTOIMMUNITY REVIEWS
- Therapeutic efficacy of three bispecific antibodies on collagen-induced arthritis mouse model
- (2014) Qingcui Li et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Guselkumab (an IL-23–specific mAb) demonstrates clinical and molecular response in patients with moderate-to-severe psoriasis
- (2014) Howard Sofen et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Induction of IL-17+ T Cell Trafficking and Development by IFN- : Mechanism and Pathological Relevance in Psoriasis
- (2014) I. Kryczek et al. JOURNAL OF IMMUNOLOGY
- Safety and efficacy of brodalumab for psoriasis after 120 weeks of treatment
- (2014) Kim Papp et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- A 52-week, open-label study of the efficacy and safety of ixekizumab, an anti-interleukin-17A monoclonal antibody, in patients with chronic plaque psoriasis
- (2014) Kenneth B. Gordon et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Secukinumab in Plaque Psoriasis — Results of Two Phase 3 Trials
- (2014) Richard G. Langley et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Phase II Randomized Study of Subcutaneous Ixekizumab, an Anti-Interleukin-17 Monoclonal Antibody, in Rheumatoid Arthritis Patients Who Were Naive to Biologic Agents or Had an Inadequate Response to Tumor Necrosis Factor Inhibitors
- (2014) Mark C. Genovese et al. Arthritis & Rheumatology
- Interleukin-17+CD8+ T Cells Are Enriched in the Joints of Patients With Psoriatic Arthritis and Correlate With Disease Activity and Joint Damage Progression
- (2014) Bina Menon et al. Arthritis & Rheumatology
- IL-17/Th17 mediated synovial inflammation is IL-22 independent
- (2013) Jan Piet van Hamburg et al. ANNALS OF THE RHEUMATIC DISEASES
- Long-term safety of ustekinumab in patients with moderate-to-severe psoriasis: final results from 5 years of follow-up
- (2013) K.A. Papp et al. BRITISH JOURNAL OF DERMATOLOGY
- Targeting Interleukin-22 in Psoriasis
- (2013) Ji-Qing Hao INFLAMMATION
- Anti-IL21 receptor monoclonal antibody (ATR-107): Safety, pharmacokinetics, and pharmacodynamic evaluation in healthy volunteers: A phase I, first-in-human study
- (2013) Fei Hua et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Biologic fatigue in psoriasis
- (2013) Ethan C. Levin et al. JOURNAL OF DERMATOLOGICAL TREATMENT
- Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trial
- (2013) Iain B McInnes et al. LANCET
- Th17 cells and IL-17 A—Focus on immunopathogenesis and immunotherapeutics
- (2013) Wim B. van den Berg et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Th17 and Th22 cells in psoriatic arthritis and psoriasis
- (2013) Helen Benham et al. ARTHRITIS RESEARCH & THERAPY
- Pharmacologic Repression of Retinoic Acid Receptor-Related Orphan Nuclear Receptor γ Is Therapeutic in the Collagen-Induced Arthritis Experimental Model
- (2013) Mi Ra Chang et al. Arthritis & Rheumatology
- Spinal Inflammation in the Absence of Sacroiliac Joint Inflammation on Magnetic Resonance Imaging in Patients With Active Nonradiographic Axial Spondyloarthritis
- (2013) Désirée van der Heijde et al. Arthritis & Rheumatology
- Serum and tissue levels of IL-17 in different clinical subtypes of psoriasis
- (2012) Senem Buyukkara Yilmaz et al. ARCHIVES OF DERMATOLOGICAL RESEARCH
- T-helper 17 cells: The driving force of psoriasis and psoriatic arthritis
- (2012) In Seol Yoo et al. International Journal of Rheumatic Diseases
- Hiding under the skin: A welcome surprise in psoriasis
- (2012) James G Krueger NATURE MEDICINE
- IL-23 induces spondyloarthropathy by acting on ROR-γt+ CD3+CD4−CD8− entheseal resident T cells
- (2012) Jonathan P Sherlock et al. NATURE MEDICINE
- Brodalumab, an Anti–Interleukin-17–Receptor Antibody for Psoriasis
- (2012) Kim A. Papp et al. NEW ENGLAND JOURNAL OF MEDICINE
- Anti–Interleukin-17 Monoclonal Antibody Ixekizumab in Chronic Plaque Psoriasis
- (2012) Craig Leonardi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Functional role of IL-22 in psoriatic arthritis
- (2012) Anupam Mitra et al. ARTHRITIS RESEARCH & THERAPY
- Interleukin-17-positive mast cells contribute to synovial inflammation in spondylarthritis
- (2011) Troy Noordenbos et al. ARTHRITIS AND RHEUMATISM
- Enrichment of circulating interleukin-17-secreting interleukin-23 receptor-positive γ/δ T cells in patients with active ankylosing spondylitis
- (2011) Tony J. Kenna et al. ARTHRITIS AND RHEUMATISM
- Distinct Roles of IL-23 and IL-17 in the Development of Psoriasis-Like Lesions in a Mouse Model
- (2011) Kimiko Nakajima et al. JOURNAL OF IMMUNOLOGY
- Mast Cells and Neutrophils Release IL-17 through Extracellular Trap Formation in Psoriasis
- (2011) A. M. Lin et al. JOURNAL OF IMMUNOLOGY
- IL-17 receptor and its functional significance in psoriatic arthritis
- (2011) Siba P. Raychaudhuri et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Suppression of TH17 differentiation and autoimmunity by a synthetic ROR ligand
- (2011) Laura A. Solt et al. NATURE
- Chronic Mucocutaneous Candidiasis in Humans with Inborn Errors of Interleukin-17 Immunity
- (2011) A. Puel et al. SCIENCE
- Role of Th17 cells in human autoimmune arthritis
- (2010) Jan Leipe et al. ARTHRITIS AND RHEUMATISM
- Cutting Edge: A Critical Functional Role for IL-23 in Psoriasis
- (2010) G. Tonel et al. JOURNAL OF IMMUNOLOGY
- IL-17 Contributes to Angiogenesis in Rheumatoid Arthritis
- (2010) S. R. Pickens et al. JOURNAL OF IMMUNOLOGY
- Cutting Edge: Mast Cells Express IL-17A in Rheumatoid Arthritis Synovium
- (2010) A. J. Hueber et al. JOURNAL OF IMMUNOLOGY
- Integrative Responses to IL-17 and TNF-α in Human Keratinocytes Account for Key Inflammatory Pathogenic Circuits in Psoriasis
- (2010) Andrea Chiricozzi et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Comparison of Ustekinumab and Etanercept for Moderate-to-Severe Psoriasis
- (2010) Christopher E.M. Griffiths et al. NEW ENGLAND JOURNAL OF MEDICINE
- Linking Power Doppler Ultrasound to the Presence of Th17 Cells in the Rheumatoid Arthritis Joint
- (2010) Nicola J. Gullick et al. PLoS One
- Remission in psoriatic arthritis: is it possible and how can it be predicted?
- (2010) Tajvur P Saber et al. ARTHRITIS RESEARCH & THERAPY
- Characterization of the interleukin-17 isoforms and receptors in lesional psoriatic skin
- (2009) C. Johansen et al. BRITISH JOURNAL OF DERMATOLOGY
- Involvement of interleukin-21 in the epidermal hyperplasia of psoriasis
- (2009) Roberta Caruso et al. NATURE MEDICINE
- Increased numbers of circulating polyfunctional Th17 memory cells in patients with seronegative spondylarthritides
- (2008) Camilla Jandus et al. ARTHRITIS AND RHEUMATISM
- Deficiency of Th17 cells in hyper IgE syndrome due to mutations inSTAT3
- (2008) Cindy S. Ma et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Psoriasis Vulgaris Lesions Contain Discrete Populations of Th1 and Th17 T Cells
- (2008) Michelle A. Lowes et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1)
- (2008) Craig L Leonardi et al. LANCET
- Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2)
- (2008) Kim A Papp et al. LANCET
- Impaired TH17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome
- (2008) Joshua D. Milner et al. NATURE
- TH-17 cells in rheumatoid arthritis
- (2008) Shiva Shahrara et al. ARTHRITIS RESEARCH & THERAPY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started